Middleware Strategy: Why It’s Critical to LIS Migration Success

For laboratories planning a major LIS migration, Epic Beaker transition, automation expansion, or multi-site standardization effort, middleware is often where the true scale of the project comes into focus.

It is where teams begin to see how much coordination, validation, regulatory review, workflow redesign, and issue resolution are required to keep the project moving. It is also where delays can start to surface, especially when legacy logic, site-specific variation, instrument connectivity, and future-state build decisions are not aligned early.

That alignment takes more than technical build. It requires someone who can translate between laboratory operations, LIS teams, middleware analysts, vendors, instrument teams, and project leadership. Without that bridge, decisions can stall, requirements can be missed, and teams can lose valuable time trying to resolve issues that should have been identified earlier in the process.

It is where legacy logic must be translated into future-state workflows. It is where site-specific variation starts competing with enterprise standardization. It is where decisions about rules, routing, mappings, autoverification, exception handling, and instrument connectivity can either protect the migration or create problems that follow the lab long after go-live.

That is why middleware cannot be treated as a late-stage technical workstream.

Too often, middleware strategy is reduced to a series of build decisions: connect this analyzer, update this rule, map this code, support this local workflow, resolve this exception. Each request may be valid on its own, but without a larger strategy, those decisions can create a fragile environment that is difficult to validate, support, optimize, and scale.

The better question is not, “How do we make middleware work?”

It is, “How should middleware support the laboratory’s future-state operating model?”

That shift matters. It forces teams to decide what should be preserved, what should be redesigned, what should be standardized, and what should not be carried forward simply because it existed in the legacy environment.

For labs already managing complex change, middleware strategy is not extra planning. It is how the organization protects continuity, reduces rework, avoids unnecessary technical debt, and builds workflows that can hold up beyond the next go-live.

JTG helps create that structure by serving as a liaison between the teams that understand the laboratory, the teams building the system, and the vendors supporting the technology. That connection can help keep decisions moving, reduce avoidable rework, and make sure middleware planning supports the broader migration strategy instead of slowing it down. 

Middleware’s Role in Large-Scale LIS Migrations 

Large-scale LIS migrations are where middleware strategy becomes impossible to ignore.

When a health system moves from a legacy LIS to a new enterprise platform, middleware often becomes one of the most important stabilizing forces in the transition. It sits at the intersection of instruments, order routing, result delivery, automation, legacy workflows, new system build, and downstream clinical access.

In a phased migration, that role becomes even more complex. Some facilities may be live on the new LIS while others remain on the legacy system. Orders and results may need to move across mixed environments. Instruments may need to support workflows tied to both current-state and future-state processes. Labels, containers, codes, result mappings, and routing logic may need to function reliably while the organization is operating in two worlds at once.

JTG’s Atrium Health migration case study illustrates the stakes. Atrium Health was moving from Cerner and Sunquest to an Epic environment across multiple states and regional waves. The project created significant technical challenges because labs needed to communicate seamlessly while some were operating on legacy systems and others were operating on the new platform. If a workable resolution was not in place, provider orders could fail to reach the lab and lab instruments, and results could fail to return to the chart for provider access.

That is the kind of scenario where middleware cannot be treated as a late-stage interface task. It has to be part of the migration architecture.

During a large LIS migration, middleware strategy should help define how orders and results will move during phased go-lives, how instruments will communicate across mixed-system environments, how mapping decisions will be governed and validated, and how middleware logic will support continuity without preserving unnecessary technical debt.

In the Atrium Health migration, JTG supported highly specific technical work, including foreign container build so that Sunquest labels could be read successfully in Epic, as well as order code and result code mapping in Atlas. That type of work may sound tactical, but it is strategic in impact. It helps protect continuity while the organization transitions from one operating model to another.

Middleware Strategy Helps Prevent Lift-and-Shift Thinking 

One of the biggest risks in any migration is recreating the old environment in the new system. 

Sometimes that is necessary for continuity. But when every legacy rule, workaround, exception, and manual review step is moved forward without evaluation, the organization misses the opportunity to improve.

Middleware strategy gives teams a framework for deciding what should be preserved, redesigned, retired, or standardized.

That is especially important because many legacy environments have years of accumulated decisions embedded in middleware logic. Some were built to solve real operational problems. Some were temporary fixes that became permanent. Some reflect outdated instrumentation, old reporting needs, historical staffing models, or site-specific preferences that no longer fit the future state.

The goal is not to overcomplicate the migration. The goal is to avoid carrying unnecessary complexity into the future.

From Go-Live Stabilization to Optimization 

Go-live is not the end of middleware work. In many ways, it is when the work becomes more visible. 

Once the new LIS is live, teams begin to see how the build, interfaces, instruments, routing logic, and operational workflows perform under real conditions. Issues may surface in error logs, result delivery, exception handling, accessioning workflows, automation behavior, user adoption, and downstream reporting.

Middleware should be part of that stabilization model from the start.

After go-live, middleware teams need a clear process for separating true production issues from optimization requests. They need defined escalation paths, documentation discipline, operational input, and a way to prioritize work based on patient care risk, lab impact, regulatory needs, and resource capacity.

This is also where middleware optimization should connect back to business goals. Reducing manual result review can improve staff efficiency. Improving instrument routing can support turnaround time. Standardizing middleware logic can simplify support across multiple sites. Strengthening error handling can reduce operational risk. Cleaner mapping and documentation can improve upgrade readiness.

Middleware strategy is not only about whether the interface works. It is about whether the workflow works better.

Governance Makes Middleware Sustainable 

Middleware environments are too important to rely on informal decision-making. 

Governance does not need to be heavy or slow. But it does need to be clear. Teams need to know how middleware requests are submitted, reviewed, prioritized, tested, approved, documented, and moved into production.

For middleware, governance should include the right voices: LIS, middleware analysts, instrument teams, laboratory operations, quality, project leadership, and vendors when needed. 

The goal is not to slow the work down. The goal is to make sure the right work is happening in the right order, with the right input, and with the right level of validation.

The Strategic Question Middleware Teams Should Be Asking 

For teams already familiar with middleware, the next level of maturity is not more technical knowledge. It is stronger alignment.

The strategic question is: 

How should middleware support the laboratory’s future-state operating model? 

That question changes the conversation. It moves middleware from a technical dependency to a planning priority. It helps teams evaluate what needs to be standardized, what needs to remain flexible, what needs to be redesigned, and what must be protected during change.

It also helps organizations avoid one of the most common Lab IT pitfalls: solving today’s issue in a way that creates tomorrow’s constraint.

Middleware decisions should not only solve for the next go-live, the next analyzer connection, or the next workflow exception. They should account for what the laboratory may need several years from now. With analyzers often expected to support operations for years, decisions made today can either create flexibility across instrumentation, staffing efficiency, workflow redesign, and interoperability needs, or unintentionally lock the organization into constraints that persist across the laboratory’s operating model.

The goal is not to predict every future requirement. The goal is to avoid designing middleware logic so tightly around today’s environment that tomorrow’s growth, replacement strategy, staffing model, or interoperability need becomes harder to support. 

Final Thought: Middleware Belongs in the Strategy Conversation 

Middleware has always been important to laboratory operations. But as health system labs become more connected, more automated, and more centralized through hub-and-spoke operating models, middleware strategy becomes even more critical. 

In these environments, middleware has to support more than individual instrument connections. It has to help standardize workflows across sites, support routing between core labs and spoke locations, preserve continuity during phased transitions, and create enough flexibility for future instrumentation, staffing, and interoperability needs.

It supports continuity during migrations. It protects workflows during phased go-lives. It helps connect instruments, automation, LIS platforms, EHRs, outreach systems, and specialty workflows. It gives teams a way to reduce manual effort, manage complexity, and build toward a more scalable future state.

For organizations planning major Lab IT change, middleware should not be addressed after the strategy is set. It should help shape the strategy from the beginning.

Preparing for an LIS migration, middleware optimization, or complex Lab IT transition?

JTG helps hospitals, health systems, and laboratories navigate LIS implementations, middleware alignment, instrument integration, validation, go-live planning, and post-live optimization. Whether your team is moving from a legacy LIS to Epic Beaker, managing phased go-lives across multiple sites, or redesigning middleware workflows for long-term scalability, JTG brings the laboratory knowledge, technical expertise, and project structure needed to move complex work forward. 

Talk to JTG about your next LIS migration or middleware optimization project.